Group One Trading’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-638
| Closed | -$21.4K | – | 8561 |
|
|
2025
Q4 | $27.3K | Sell |
638
-1,983
| -76% | -$74.8K | ﹤0.01% | 6103 |
|
|
2025
Q3 | $74.3K | Buy |
+2,621
| New | +$78.4K | ﹤0.01% | 5604 |
|
|
2024
Q1 | – | Sell |
-488
| Closed | -$6.58K | – | 7823 |
|
|
2023
Q4 | $7.08K | Sell |
488
-10
| -2% | -$102 | ﹤0.01% | 6365 |
|
|
2023
Q3 | $5.38K | Buy |
+498
| New | +$5.99K | ﹤0.01% | 6666 |
|
|
2023
Q1 | – | Sell |
-1,113
| Closed | -$17.7K | – | 7839 |
|
|
2022
Q4 | $16.7K | Sell |
1,113
-3,984
| -78% | -$36.5K | ﹤0.01% | 5716 |
|
|
2022
Q3 | $60K | Buy |
5,097
+639
| +14% | +$8.64K | ﹤0.01% | 5245 |
|
|
2022
Q2 | $50K | Sell |
4,458
-995
| -18% | -$20K | ﹤0.01% | 5556 |
|
|
2022
Q1 | $163K | Sell |
5,453
-6,219
| -53% | -$168K | ﹤0.01% | 5018 |
|
|
2021
Q4 | $309K | Sell |
11,672
-667
| -5% | -$20.1K | ﹤0.01% | 4632 |
|
|
2021
Q3 | $448K | Buy |
12,339
+10,102
| +452% | +$398K | ﹤0.01% | 4323 |
|
|
2021
Q2 | $97K | Buy |
+2,237
| New | +$84.5K | ﹤0.01% | 5995 |
|
|
2021
Q1 | – | Sell |
-4,284
| Closed | -$170K | – | 7952 |
|
|
2020
Q4 | $150K | Buy |
+4,284
| New | +$124K | ﹤0.01% | 4280 |
|
|
2019
Q2 | – | Sell |
-8,390
| Closed | -$189K | – | 5324 |
|
|
2019
Q1 | $216K | Buy |
8,390
+8,153
| +3,440% | +$186K | ﹤0.01% | 2644 |
|
|
2018
Q4 | $5K | Buy |
+237
| New | +$6.69K | ﹤0.01% | 4476 |
|
|
2018
Q1 | – | Sell |
-834
| Closed | -$33.4K | – | 5237 |
|
|
2017
Q4 | $32K | Buy |
834
+360
| +76% | +$13.7K | ﹤0.01% | 3955 |
|
|
2017
Q3 | $12K | Sell |
474
-90
| -16% | -$2.19K | ﹤0.01% | 4239 |
|
|
2017
Q2 | $15K | Buy |
+564
| New | +$15.4K | ﹤0.01% | 4058 |
|
|
2016
Q3 | – | Sell |
-5,522
| Closed | -$158K | – | 4852 |
|
|
2016
Q2 | $123K | Buy |
5,522
+4,728
| +595% | +$118K | ﹤0.01% | 2720 |
|
|
2016
Q1 | $17K | Buy |
+794
| New | +$19.6K | ﹤0.01% | 3827 |
|
|
2015
Q3 | – | Sell |
-3,071
| Closed | -$91.7K | – | 5134 |
|
|
2015
Q2 | $99K | Buy |
+3,071
| New | +$117K | ﹤0.01% | 3098 |
|
|
2015
Q1 | – | Sell |
-5
| Closed | -$137 | – | 5106 |
|
|
2014
Q4 | $0 | Buy |
+5
| New | +$101 | ﹤0.01% | 5214 |
|
|
2014
Q1 | – | Sell |
-1,658
| Closed | -$59.1K | – | 5518 |
|
|
2013
Q4 | $47K | Sell |
1,658
-168
| -9% | -$4.93K | ﹤0.01% | 3665 |
|
|
2013
Q3 | $65K | Buy |
+1,826
| New | +$66.6K | ﹤0.01% | 3362 |
|
Other funds holding RIGL
AC
VCM
Group One Trading's RIGL Position: Q1 2026 in Review
Group One Trading sold out of Rigel Pharmaceuticals (RIGL) in Q1 2026, closing a stake of 638 shares — an estimated $21.4K sold.
Group One Trading first reported a position in RIGL in Q3 2013 and held it in 23 quarters. The position peaked at $448K in Q3 2021. 159 funds tracked by Wall St. Rank hold RIGL as of Q1 2026.
- Group One Trading reported no remaining Rigel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
- Group One Trading sold 638 Rigel Pharmaceuticals shares in Q1 2026, an estimated $21.4K.
- Group One Trading first reported a position in Rigel Pharmaceuticals in Q3 2013 and held it in 23 quarters.
- Group One Trading's Rigel Pharmaceuticals position peaked at $448K in Q3 2021.
- 159 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.